Permanent URL to this publication: http://dx.doi.org/10.5167/uzh-49953
Heinrich, S; Pestalozzi, B; Lesurtel, M; Berrevoet, F; Laurent, S; Delpero, J R; Raoul, J L; Bachellier, P; Dufour, P; Moehler, M; Weber, A; Lang, H; Rogiers, X; Clavien, P A (2011). Adjuvant gemcitabine versus NEOadjuvant gemcitabine/oxaliplatin plus adjuvant gemcitabine in resectable pancreatic cancer: a randomized multicenter phase III study (NEOPAC study). BMC Cancer, 11:346.
![[img]](http://www.zora.uzh.ch/style/images/fileicons/application_pdf.png)
| Published Version 770Kb |
| Item Type: | Journal Article, refereed, original work |
|---|---|
| Communities & Collections: | 04 Faculty of Medicine > University Hospital Zurich > Institute of Surgical Pathology 04 Faculty of Medicine > University Hospital Zurich > Clinic for Visceral and Transplantation Surgery |
| DDC: | 610 Medicine & health |
| Language: | German |
| Date: | 2011 |
| Deposited On: | 19 Oct 2011 13:19 |
| Last Modified: | 24 Nov 2012 11:01 |
| Publisher: | BioMed Central |
| ISSN: | 1471-2407 |
| Funders: | Swiss National Foundation, Sasella Foundation, Stiftung zur Krebsbekämpfung Zürich, Sanofi-Aventis, TEVA Pharma |
| Publisher DOI: | 10.1186/1471-2407-11-346 |
| PubMed ID: | 21831266 |
Users (please log in): suggest update or correction for this item
Repository Staff Only: item control page
